A5058822901- Spondyloarthritis Studies and Treatments
- Autoimmune and Inflammatory Disorders Research
- Rheumatoid Arthritis Research and Therapies
- Bone and Joint Diseases
- Psoriasis: Treatment and Pathogenesis
- Venous Thromboembolism Diagnosis and Management
- Atrial Fibrillation Management and Outcomes
- Systemic Sclerosis and Related Diseases
- Chronic Lymphocytic Leukemia Research
Hospital Italiano de Buenos Aires
2019-2024
Services Hospital
2024
<h3>Background</h3> Rheumatoid arthritis (RA), psoriatic (PsA) and axial spondyloarthritis (axSpA) are diseases where inflammation plays a key role in their development have an increased risk of developing comorbid conditions. It is important to evaluate the comorbidities associated with these diseases. <h3>Objectives</h3> Our objective was prevalence RA, PsA axSpA patients from PANLAR´s register rheumatic (PANRED). <h3>Methods</h3> PANRED includes real world data Latin American consecutive...
Introduction There is scarce information on the prevalence of axial spondylarthritis (axSpA) using Assessment SpondyloArthritis International Society (ASAS) criteria and even less in Latin America. This study aimed to estimate axSpA by applying ASAS 2009 a medical records review young people with chronic low back pain (LBP) at university hospital–based health management organization. Methods Electronic from Hospital Italiano de Buenos Aires organization were reviewed (radiographic [r-axSpA]...
time to diagnosis, impact and information) for AAV patients that discussed on online.
Background: Axial spondyloarthritis (SpA) is an umbrella term encompassing a number of inflammatory conditions involving the axial skeleton. A substantial delay between disease onset, diagnosis and treatment often occurs, related in part to under-recognition SpA symptoms. Although several studies have investigated since publication ASAS classification criteria 2009, prevalence incidence general population patients with SpA-related conditions, actual many countries (including Argentina)...